$988.62
In chiusura: Nov 11, 7:55 PM EDT
$990.00
1.380.14%
After hour: 7:55 PM EDT
Eli Lilly segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Eli Lilly utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly | $5.32 | $7.19 | — | — | $13.53B | $17.73B | — | — | 02/05/2026 | |
LLY | Eli Lilly | $1.18 | $5.96 | $7.02 | 17.79% | $11.44B | $16.05B | $17.60B | 9.69% | 10/30/2025 | |
LLY | Eli Lilly | $3.92 | $5.60 | $6.31 | 12.68% | $11.30B | $14.70B | $15.56B | 5.83% | 08/07/2025 | |
LLY | Eli Lilly | $2.58 | $3.02 | $3.34 | 10.60% | $8.77B | $12.66B | $12.73B | 0.55% | 05/01/2025 | |
LLY | Eli Lilly | $2.49 | $5.08 | $5.32 | 4.72% | $9.35B | $13.43B | $13.53B | 0.77% | 02/06/2025 | |
LLY | Eli Lilly | $0.10 | $1.45 | $1.18 | -18.62% | $9.50B | $12.10B | $11.44B | -5.46% | 10/30/2024 | |
LLY | Eli Lilly | $2.11 | $2.70 | $3.92 | 45.19% | $8.31B | $9.95B | $11.30B | 13.60% | 08/08/2024 | |
LLY | Eli Lilly | $1.62 | $2.46 | $2.58 | 4.88% | $6.96B | $8.92B | $8.77B | -1.70% | 04/30/2024 | |
LLY | Eli Lilly | $2.09 | $2.19 | $2.49 | 13.70% | $7.30B | $8.93B | $9.35B | 4.74% | 02/06/2024 | |
LLY | Eli Lilly | $1.98 | -$0.15 | $0.10 | 166.67% | $6.94B | $8.95B | $9.50B | 6.13% | 11/02/2023 | |
LLY | Eli Lilly | $1.25 | $1.99 | $2.11 | 6.03% | $6.49B | $7.58B | $8.31B | 9.66% | 08/08/2023 | |
LLY | Eli Lilly | $2.62 | $1.73 | $1.62 | -6.36% | $7.81B | $6.86B | $6.96B | 1.46% | 04/27/2023 | |
LLY | Eli Lilly | $2.49 | $1.78 | $2.09 | 17.42% | $8.00B | $7.33B | $7.30B | -0.38% | 02/02/2023 | |
LLY | Eli Lilly | $1.77 | $1.92 | $1.98 | 3.12% | $6.77B | $6.91B | $6.94B | 0.46% | 11/01/2022 | |
LLY | Eli Lilly | $1.87 | $1.69 | $1.25 | -26.04% | $6.74B | $6.70B | $6.49B | -3.16% | 08/04/2022 | |
LLY | Eli Lilly | $1.87 | $2.13 | $2.62 | 23.00% | $6.81B | $6.68B | $7.81B | 16.92% | 04/28/2022 | |
LLY | Eli Lilly | $2.75 | $2.19 | $2.49 | 13.70% | $7.44B | $6.90B | $8.00B | 15.94% | 02/03/2022 | |
LLY | Eli Lilly | $1.54 | $1.68 | $1.94 | 15.48% | $5.74B | $5.70B | $6.77B | 18.82% | 10/26/2021 | |
LLY | Eli Lilly | $1.89 | $1.92 | $1.87 | -2.60% | $5.50B | $6.65B | $6.74B | 1.35% | 08/03/2021 | |
LLY | Eli Lilly | $1.75 | $2.14 | $1.87 | -12.62% | $5.86B | $7.02B | $6.81B | -3.05% | 04/27/2021 | |
LLY | Eli Lilly | $1.73 | $2.35 | $2.75 | 17.02% | $6.11B | $7.29B | $7.44B | 2.06% | 01/29/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $7.02 | $5.96 | 17.8 % |
| Q2 | 2025-08-07 | $6.31 | $5.60 | 12.7 % |
| Q1 | 2025-05-01 | $3.34 | $3.02 | 10.6 % |
| Q4 | 2025-02-06 | $5.32 | $5.08 | 4.72 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | 2025-10-30 | $17.60B | $16.05B | 9.69 % |
| Q2 | 2025-08-07 | $15.56B | $14.70B | 5.83 % |
| Q1 | 2025-05-01 | $12.73B | $12.66B | 0.55 % |
| Q4 | 2025-02-06 | $13.53B | $13.43B | 0.77 % |
Si prevede che Eli Lilly (LLY) fornisca risultati il febbraio 5, 2026. Gli ultimi risultati sono stati pubblicati il ottobre 30, 2025 per il Q3.
L'EPS effettivo era $7.02, che superato la stima di $5.96.
Le entrate effettive sono state $17.6B, che superato la stima di $16B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.